Dixie Group (DXYN) gave turnaround skeptics something they had not seen in a while: top-line growth and a profitable quarter in the same report. Income from continuing operations was $0.05 per diluted share on revenue of $65.23 million for the quarter ended September 2026. That compares with a loss of $0.28 a year ago, which Earnings Whispers translates into 117.9% earnings growth. Revenue rose 4.6% year over year. GAAP net income, including discontinued operations, was $577,000 ($0.04 per share), versus a $4.1 million loss, marking a third consecutive profitable quarter. No consensus estimate was available, so the quarter has to be judged on its own trajectory. On that basis, the central tension is clear. Sales are finally accelerating, but the margin and cost improvements behind the profit are less clean than the headline suggests, and management is already warning of a fourth-quarter squeeze.
The revenue story is the most convincing part of the report. Sales went from a 5.7% decline in the first quarter to flat in the second quarter to 4.6% growth now. Soft surface sales rose 7.1% against what management described as a roughly flat industry, led by DuraSilkSD polyester and EnVisionSD nylon. Fabrica wood grew 15.3%, although hard surface sales overall declined. For a company operating in a housing market where existing home sales sit at historic lows for a fourth straight year, outgrowing the industry is a genuine accomplishment.
The quality of the earnings improvement deserves scrutiny. Operating income swung $4.4 million, from a $2.0 million loss to a $2.4 million profit. That gain came from three sources:
- roughly $1.9 million from higher gross profit;
- a $1.7 million drop in selling and administrative expense;
- about $0.9 million from lower other operating expense.
The SG&A decline was aided by capitalizing sample display structures, and part of that true-up related to prior quarters. Some of the expense relief is therefore accounting timing rather than repeatable savings. Gross margin improved 180 basis points year over year to 26.6%, but it fell well short of the 29.5% posted in the second quarter. Adjusted year-to-date gross margin, which strips out the IEEPA tariff refund, slipped to 28.2% through the third quarter from 29.1% through the second. Below the operating line, $1.9 million of interest expense consumed most of operating income, leaving just $640,000 of pretax profit before a small tax benefit.
The call shifted the near-term outlook. Management expects fourth-quarter margins to be "somewhat impacted" as oil-linked raw material and freight costs, along with faster-than-expected medical costs, outrun pricing. A second industry-wide price increase began rolling out in early November, and management expects "more normal" margins by the first quarter of 2027. That makes pricing realization the key catalyst to watch. Demand signals also cooled. Fourth-quarter order entry is only "slightly ahead" of last year, down from the mid-single-digit growth cited on the prior call. On the positive side, the profit improvement plan was raised to about $18 million from roughly $17 million and is largely achieved, and a new plan for next year is in development. No formal guidance was provided.
The balance sheet is where bears have their most legitimate ammunition. The current portion of long-term debt stands at $58.9 million against just $3.7 million of cash, and stockholders' equity is only $11.7 million. Year-to-date interest expense rose to $5.8 million from $5.4 million. Borrowing availability did improve to about $14.5 million from $13.3 million in the second quarter and $10.2 million in the first. The board is also weighing asset-backed financing, which could matter as much to the equity story as any margin trend. Buyback authority exists but is not being used.
Market context is thin. No investor sentiment readings, current price, or technical levels were available for this report. The one reference point is the stock's $0.43 opening price after the August report, a level showing how much distress the market had already priced in. Against that backdrop, even a modest profit carries weight, but the fourth-quarter margin warning and the financing overhang leave little room for error.
The bottom line is that Dixie delivered real progress on the top line, with sales growth reaccelerating and soft surface gaining share in a stagnant market. However, sequential margin compression, a one-time boost to SG&A, slowing order entry, and a heavily leveraged balance sheet keep the turnaround provisional. The next two quarters hinge on whether the November price increase restores margins and whether management can secure financing that eases pressure on the equity.